China is reportedly giving 'extra scrutiny' to any research on the coronavirus' origins
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
China is reportedly requiring academic research into the origin of the novel coronavirus to receive additional scrutiny and approval by the government.
Academic papers on COVID-19 under a new policy from China "will be subject to extra vetting before being submitted for publication," and research on the virus' origins will "receive extra scrutiny and must be approved by central government officials," CNN reports.
A directive from the Ministry of Education specifies that "academic papers about tracing the origin of the virus must be strictly and tightly managed." Papers must reportedly undergo vetting from a State Council task force after being sent to the Education Ministry.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The novel coronavirus first emerged in Wuhan, and since then, CNN notes that some research into questions like when there was first human-to-human transmission of the virus have called the Chinese government's account into question. A Chinese diplomat recently pushed a conspiracy theory that the virus originated in the United States, and the U.S. intelligence community has reportedly concluded that China has underreported its number of coronavirus cases.
One Chinese researcher who spoke to CNN characterized these restrictions as part of "a coordinated effort from [the] Chinese government to control [the] narrative, and paint it as if the outbreak did not originate in China," adding, "I don't think they will really tolerate any objective study to investigate the origination of this disease."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
‘Poor time management isn’t just an inconvenience’Instant Opinion Opinion, comment and editorials of the day
-
Bad Bunny’s Super Bowl: A win for unityFeature The global superstar's halftime show was a celebration for everyone to enjoy
-
Book reviews: ‘Bonfire of the Murdochs’ and ‘The Typewriter and the Guillotine’Feature New insights into the Murdoch family’s turmoil and a renowned journalist’s time in pre-World War II Paris
-
A Nipah virus outbreak in India has brought back Covid-era surveillanceUnder the radar The disease can spread through animals and humans
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
